179 related articles for article (PubMed ID: 21074229)
21. Evaluation of a porcine circovirus type 2a (PCV2a) vaccine efficacy against experimental PCV2a, PCV2b, and PCV2d challenge.
Park KH; Oh T; Yang S; Cho H; Kang I; Chae C
Vet Microbiol; 2019 Apr; 231():87-92. PubMed ID: 30955830
[TBL] [Abstract][Full Text] [Related]
22. Effect of porcine parvovirus vaccination on the development of PMWS in segregated early weaned pigs coinfected with type 2 porcine circovirus and porcine parvovirus.
Opriessnig T; Fenaux M; Yu S; Evans RB; Cavanaugh D; Gallup JM; Pallares FJ; Thacker EL; Lager KM; Meng XJ; Halbur PG
Vet Microbiol; 2004 Mar; 98(3-4):209-20. PubMed ID: 15036529
[TBL] [Abstract][Full Text] [Related]
23. A commercial PCV2a-based vaccine is effective in protection from experimental challenge of PCV2 mutant with two amino acids elongation in capsid protein.
Guo LJ; Fu YJ; Huang LP; Wang YP; Wei YW; Wu HL; Liu CM
Vaccine; 2015 Jul; 33(31):3752-7. PubMed ID: 26051516
[TBL] [Abstract][Full Text] [Related]
24. [Occurrence of genotypes of porcine circovirus (PCV2) in pig farms using different vaccination strategies against PCV2].
Eddicks M; Szikora F; Walhöfer N; Sauter Louis C; Reese S; Banholzer E; Reiner G; Sutter G; Ritzmann M; Fux R
Tierarztl Prax Ausg G Grosstiere Nutztiere; 2017 Apr; 45(2):90-97. PubMed ID: 28327779
[TBL] [Abstract][Full Text] [Related]
25. Differences in virulence among porcine circovirus type 2 isolates are unrelated to cluster type 2a or 2b and prior infection provides heterologous protection.
Opriessnig T; Ramamoorthy S; Madson DM; Patterson AR; Pal N; Carman S; Meng XJ; Halbur PG
J Gen Virol; 2008 Oct; 89(Pt 10):2482-2491. PubMed ID: 18796717
[TBL] [Abstract][Full Text] [Related]
26. Experimental transmission of porcine circovirus type 2 (PCV2) in weaned pigs: a sequential study.
Magar R; Larochelle R; Thibault S; Lamontagne L
J Comp Pathol; 2000 Nov; 123(4):258-69. PubMed ID: 11041995
[TBL] [Abstract][Full Text] [Related]
27. Prevalence and phylogenetic analysis of the current porcine circovirus 2 genotypes after implementation of widespread vaccination programmes in the USA.
Shen HG; Halbur PG; Opriessnig T
J Gen Virol; 2012 Jun; 93(Pt 6):1345-1355. PubMed ID: 22398315
[TBL] [Abstract][Full Text] [Related]
28. A commercial vaccine based on PCV2a and an experimental vaccine based on a variant mPCV2b are both effective in protecting pigs against challenge with a 2013 U.S. variant mPCV2b strain.
Opriessnig T; Gerber PF; Xiao CT; Mogler M; Halbur PG
Vaccine; 2014 Jan; 32(2):230-7. PubMed ID: 24269319
[TBL] [Abstract][Full Text] [Related]
29. A Porcine circovirus type 2b (PCV2b)-based experimental vaccine is effective in the PCV2b-Mycoplasma hyopneumoniae coinfection pig model.
Opriessnig T; Castro AMMG; Karuppanan AK; Gauger PC; Halbur PG; Matzinger SR; Meng XJ
Vaccine; 2019 Oct; 37(44):6688-6695. PubMed ID: 31537445
[TBL] [Abstract][Full Text] [Related]
30. The open reading frame 3 (ORF3) of porcine circovirus type 2 (PCV2) is dispensable for virus infection but evidence of reduced pathogenicity is limited in pigs infected by an ORF3-null PCV2 mutant.
Juhan NM; LeRoith T; Opriessnig T; Meng XJ
Virus Res; 2010 Jan; 147(1):60-6. PubMed ID: 19852989
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of cell-mediated immune responses against porcine circovirus type 2 (PCV2) Cap and Rep proteins after vaccination with a commercial PCV2 sub-unit vaccine.
Fort M; Sibila M; Nofrarías M; Pérez-Martín E; Olvera A; Mateu E; Segalés J
Vet Immunol Immunopathol; 2012 Nov; 150(1-2):128-32. PubMed ID: 23010221
[TBL] [Abstract][Full Text] [Related]
32. Infectivity of porcine circovirus type 2 DNA in semen from experimentally-infected boars.
Madson DM; Ramamoorthy S; Kuster C; Pal N; Meng XJ; Halbur PG; Opriessnig T
Vet Res; 2009; 40(1):10. PubMed ID: 18973743
[TBL] [Abstract][Full Text] [Related]
33. Excessive porcine circovirus type 2 antibody titres may trigger the development of porcine dermatitis and nephropathy syndrome: a case-control study.
Wellenberg GJ; Stockhofe-Zurwieden N; de Jong MF; Boersma WJ; Elbers AR
Vet Microbiol; 2004 Apr; 99(3-4):203-14. PubMed ID: 15066723
[TBL] [Abstract][Full Text] [Related]
34. Correlation between the presence of neutralizing antibodies against porcine circovirus 2 (PCV2) and protection against replication of the virus and development of PCV2-associated disease.
Meerts P; Misinzo G; Lefebvre D; Nielsen J; Bøtner A; Kristensen CS; Nauwynck HJ
BMC Vet Res; 2006 Jan; 2():6. PubMed ID: 16445856
[TBL] [Abstract][Full Text] [Related]
35. Reproductive failure experimentally induced in sows via artificial insemination with semen spiked with porcine circovirus type 2.
Madson DM; Patterson AR; Ramamoorthy S; Pal N; Meng XJ; Opriessnig T
Vet Pathol; 2009 Jul; 46(4):707-16. PubMed ID: 19276045
[TBL] [Abstract][Full Text] [Related]
36. Porcine circovirus type 2a or 2b based experimental vaccines provide protection against PCV2d/porcine parvovirus 2 co-challenge.
Opriessnig T; Karuppannan AK; Halbur PG; Calvert JG; Nitzel GP; Matzinger SR; Meng XJ
Vaccine; 2020 Feb; 38(8):1975-1981. PubMed ID: 31974016
[TBL] [Abstract][Full Text] [Related]
37. Antigenic subtyping and epitopes' competition analysis of porcine circovirus type 2 using monoclonal antibodies.
Saha D; Huang L; Bussalleu E; Lefebvre DJ; Fort M; Van Doorsselaere J; Nauwynck HJ
Vet Microbiol; 2012 May; 157(1-2):13-22. PubMed ID: 22176764
[TBL] [Abstract][Full Text] [Related]
38. Effect of porcine circovirus type 2 (PCV2) vaccination on porcine reproductive and respiratory syndrome virus (PRRSV) and PCV2 coinfection.
Opriessnig T; Madson DM; Prickett JR; Kuhar D; Lunney JK; Elsener J; Halbur PG
Vet Microbiol; 2008 Sep; 131(1-2):103-14. PubMed ID: 18430525
[TBL] [Abstract][Full Text] [Related]
39. Association of concurrent porcine circovirus (PCV) 2a and 2b infection with PCV associated disease in vaccinated pigs.
Gerber PF; Johnson J; Shen H; Striegel D; Xiao CT; Halbur PG; Opriessnig T
Res Vet Sci; 2013 Oct; 95(2):775-81. PubMed ID: 23829995
[TBL] [Abstract][Full Text] [Related]
40. Genetic variation of porcine circovirus type 2 (PCV2) and its relevance to vaccination, pathogenesis and diagnosis.
Trible BR; Rowland RR
Virus Res; 2012 Mar; 164(1-2):68-77. PubMed ID: 22198217
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
